Phase I Studies of a Novel Pulsatile FXR Ligand for Treating Cholestatic Liver Diseases

linafexor (CS0159) - Cascade Pharma

Guanguan Zhao 1; Jingjing Shi 1; Gaihong Wang 1; Hualing Pan 1; Shengsheng Yang 1; Rong Deng 1; Zhenwei Zhang 1; Jia Li 2; Eric H Xu 1, 2

Jan 4, 2025